✦ LIBER ✦
PD-039 A phase II study of cetuximab (C225) in combination withchemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial
✍ Scribed by Blumenschein, G.; Swann, S.; Curran, W.; Robert, F.; Werner Wasik, M.; Jafar, S.; Lee, C.; Share, R.; Choy, H.; Komaki, R.
- Book ID
- 118572786
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 124 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.